08/17/2026 | Press release | Distributed by Public on 08/17/2026 14:10
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) On August 11, 2026, in connection with Mr. Naor's appointment (as described below), Francis X. Brown III's appointment as Neuronetics, Inc.'s (the "Company") interim principal financial and accounting officer ended. Such event is not the result of any dispute or disagreement between Mr. Brown and the Company, the Company's management, or the Company's Board on any matter relating to the Company's operations, policies, or practices. Mr. Brown will continue to serve as a consultant.
(c) As previously disclosed, the Board of Directors of the Company (the "Board") appointed Nir Naor as the Company's Executive Vice President, Chief Financial Officer, and Treasurer with an effective date of July 23, 2026. On August 12, 2026, the Board appointed Mr. Naor to serve as the Company's principal financial and accounting officer. Mr. Naor's title is now Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer. Mr. Naor did not receive any new compensation in connection with his appointment as the principal financial and accounting officer, his appointment as the corporate secretary, or the modification of his title. Mr. Naor's biographical information can be found in the Company's Current Report on Form 8-K filed on July 20, 2026.
There is no arrangement or understanding between Mr. Naor and any other person pursuant to which Mr. Naor was selected as an officer of the Company, and there is no family relationship between Mr. Naor and any of the Company's directors or other executive officers. There are no related party transactions between Mr. Naor and the Company that would require disclosure under Item 404(a) of Regulation S-K.